Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SIMPONI ARIA safely and effectively. See full prescribing information for SIMPONI ARIA. SIMPONI ARIA ®(golimumab) injection, for intravenous use Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
SIMPONI ARIA, in combination with methotrexate (MTX), is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis. SIMPONI ARIA is indicated for the treatment of active psoriatic arthritis in patients 2 years of age and older. SIMPONI ARIA is indicated for the treatment of adult patients with active ankylosing spondylitis. SIMPONI ARIA is indicated for the treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older.
- generic_name
- golimumab
- product_names
- golimumab
- ndc
- 57894-350, 57894-350-01, 57894-350-89
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en